XML 109 R83.htm IDEA: XBRL DOCUMENT
v3.25.1

Related Parties - Restricted Stock Program (Detail) R$ / shares in Units, R$ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2024 BRL (R$) shares R$ / shares
Disclosure of transactions between related parties [line items] |
Number of shares granted (Quantity) | shares | 18,521,704
Total exercisable grant costs, including taxes | R$ 622,792
Accumulated recognized exercisable grant costs | (183,017)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 439,775
Restricted Stock Award [Member] | Grant Date, September 2, 2019 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 2, 2019
Number of shares granted (Quantity) | shares | 240,000
Vesting period | 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 16.42
Total exercisable grant costs, including taxes | R$ 6,774
Accumulated recognized exercisable grant costs | (6,024)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 750
Restricted Stock Award [Member] | Grant Date, April 1, 2020 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 1, 2020
Number of shares granted (Quantity) | shares | 39,084
Vesting period | 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 12.53
Total exercisable grant costs, including taxes | R$ 1,124
Accumulated recognized exercisable grant costs | (1,074)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 50
Restricted Stock Award [Member] | Grant Date, September 16, 2020 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 16, 2020
Number of shares granted (Quantity) | shares | 140,000
Vesting period | 2026
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 23.03
Total exercisable grant costs, including taxes | R$ 5,464
Accumulated recognized exercisable grant costs | (3,946)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 1,518
Restricted Stock Award [Member] | Grant Date, September 22, 2021 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 22, 2021
Number of shares granted (Quantity) | shares | 1,000,000
Vesting period | 2027
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.17
Total exercisable grant costs, including taxes | R$ 24,093
Accumulated recognized exercisable grant costs | (13,339)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 10,754
Restricted Stock Award [Member] | Grant Date, April 6, 2022 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 6, 2022
Number of shares granted (Quantity) | shares | 634,165
Vesting period | 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.16
Total exercisable grant costs, including taxes | R$ 16,906
Accumulated recognized exercisable grant costs | (15,508)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 1,398
Restricted Stock Award [Member] | Grant Date, September 21, 2022 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 21, 2022
Number of shares granted (Quantity) | shares | 2,640,000
Vesting period | 2032
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 12.98
Total exercisable grant costs, including taxes | R$ 64,048
Accumulated recognized exercisable grant costs | (14,945)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 49,103
Restricted Stock Award [Member] | Grant Date, December 7, 2022 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | December 7, 2022
Number of shares granted (Quantity) | shares | 1,500,000
Vesting period | 2032
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 13.47
Total exercisable grant costs, including taxes | R$ 37,711
Accumulated recognized exercisable grant costs | (7,860)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 29,851
Restricted Stock Award [Member] | Grant Date, April 20, 2023 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 20, 2023
Number of shares granted (Quantity) | shares | 311,324
Vesting period | 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.5
Total exercisable grant costs, including taxes | R$ 7,472
Accumulated recognized exercisable grant costs | (6,538)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 934
Restricted Stock Award [Member] | Grant Date, April 20, 2023 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 20, 2023
Number of shares granted (Quantity) | shares | 1,146,194
Vesting period | 2026
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.5
Total exercisable grant costs, including taxes | R$ 31,039
Accumulated recognized exercisable grant costs | (18,129)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 12,910
Restricted Stock Award [Member] | Grant Date, September 20, 2023 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 20, 2023
Number of shares granted (Quantity) | shares | 3,800,000
Vesting period | 2033
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 18.75
Total exercisable grant costs, including taxes | R$ 132,784
Accumulated recognized exercisable grant costs | (17,712)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 115,072
Restricted Stock Award [Member] | Grant Date April 17 2024 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 17, 2024
Number of shares granted (Quantity) | shares | 3,495,953
Vesting period | 2027 to 2029
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 26.94
Total exercisable grant costs, including taxes | R$ 177,651
Accumulated recognized exercisable grant costs | (31,656)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 145,995
Restricted Stock Award [Member] | Grant Date June 19 2024 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | June 19, 2024
Number of shares granted (Quantity) | shares | 60,683
Vesting period | 2027
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 21.47
Total exercisable grant costs, including taxes | R$ 2,468
Accumulated recognized exercisable grant costs | (411)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 2,057
Restricted Stock Award [Member] | Grant Date October 1 2024 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | October 1, 2024
Number of shares granted (Quantity) | shares | 1,295,000
Vesting period | 2034
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 23.1
Total exercisable grant costs, including taxes | R$ 55,785
Accumulated recognized exercisable grant costs | (1,395)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 54,390
Performance Stock Award [Member] | Grant Date, April 1, 2020 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 1, 2020
Number of shares granted (Quantity) | shares | 55,074
Vesting period | 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 12.53
Total exercisable grant costs, including taxes | R$ 1,324
Accumulated recognized exercisable grant costs | (1,268)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 56
Performance Stock Award [Member] | Grant Date, April 6, 2022 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 6, 2022
Number of shares granted (Quantity) | shares | 1,007,324
Vesting period | 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.16
Total exercisable grant costs, including taxes | R$ 26,829
Accumulated recognized exercisable grant costs | (24,802)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 2,027
Performance Stock Award [Member] | Grant Date, April 20, 2023 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 20, 2023
Number of shares granted (Quantity) | shares | 1,156,903
Vesting period | 2026
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.5
Total exercisable grant costs, including taxes | R$ 31,320
Accumulated recognized exercisable grant costs | (18,410)
Unrecognized exercisable grant costs (in R$ thousands) | R$ 12,910

X
- Definition The date on which share-based payment arrangements are granted. [Refer: Types of share-based payment arrangements [domain]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_a&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph IG23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_IG23&doctype=Implementation%20Guidance -URIDate 2024-03-27 + Details
Name: | ifrs-full_DateOfGrantOfSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Types of share-based payment arrangements [domain]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 51 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_51_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of accumulated recognized grant costs arising from share-based payment transactions. + References No definition available. + Details
Name: | ugp_AccumulatedRecognizedExercisableGrantCosts
Namespace Prefix: | ugp_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of accumulated unrecognized grant costs arising from share-based payment transactions. + References No definition available. + Details
Name: | ugp_AccumulatedUnrecognizedExercisableGrantCosts
Namespace Prefix: | ugp_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ugp_SharebasedPaymentPlanNameAxis=ugp_RestrictedStockAwardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember22019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril12020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember162020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember222021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril62022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember212022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateDecember72022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril202023OneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril202023TwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember202023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril172024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateJune192024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateOctober12024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ugp_SharebasedPaymentPlanNameAxis=ugp_PerformanceStockAwardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |